Skip to content

Handheld Ultrasound (HHUS) for Home Use in Hemophilia

Handheld Ultrasound (HHUS) for Home Use in Hemophilia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04131920
Acronym
HHUS
Enrollment
10
Registered
2019-10-18
Start date
2019-10-01
Completion date
2022-06-22
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia A, Joint Bleed

Keywords

Joint Bleed, Hemophilia A, Handheld Ultrasound

Brief summary

This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a bleed or not.

Detailed description

This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a bleed or not. Phase 1 will assess whether 10 subjects with severe hemophilia A can be trained to use HHUS in clinic to identify basic joint structures of the elbow, knee and ankle. It will then assess whether these subjects can identify these structures at home and transmit the images life via tele-ultrasound. Phase 2 will assess whether the determination of bleed vs. non-bleed made at home via HHUS can be confirmed/validated with a standard high resolution ultrasound machine in clinic. Phase 3 will then utilize HHUS during the EmiMSKUS study over 3 years to more objectively identify patient reported bleeding during the study.

Interventions

DEVICEhandheld ultrasound: Philips Lumify integrated tele-ultrasound powered by Reacts collaborative platform

Patients receive training by the physical therapist to operate a handheld ultrasound (HHUS) including proper probe placement. Subjects will be tested on their knowledge at the HTC to demonstrate proficiency, and will then repeat the testing at home via tele-ultrasound.

Sponsors

Genentech, Inc.
CollaboratorINDUSTRY
Washington Institute for Coagulation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Severe hemophilia A * Male * Over 18 years of age * Able to read, write and understand English * Willing to come to the center for an 8 hour training session * Lives in proximity of the HTC and is willing to come in for acute joint episodes in phase 2 * Willing and able to follow study procedures * Willing and able to keep HHUS at a safe place * Have the dexterity to operate a HHUS unit

Exclusion criteria

* Unable to follow study instructions * Physically or mentally unable to operate a HHUS unit

Design outcomes

Primary

MeasureTime frameDescription
Outcome 1.1: Participant understanding of basic ultrasound transducer concepts and ability to perform basic positioning maneuvers.3 monthsNumber of participating subjects who understand basic ultrasound transducer concepts and can perform basic positioning maneuvers based on post-training test.
Outcome 1.2: Participating subjects are able to perform basic transducer positions and identify basic structures of the elbow, knee and ankle.3 monthsNumber of participating subjects who are able to perform basic transducer positions and identify basic structures of the elbow, knee and ankle based on post-training test.
Outcome 1.3: Participating subjects can perform what they learned during their training at the HTC in outcome 1.1 and outcome 1.2 at home and transmit images to the HTC.3 monthsNumber of participating subjects who can perform what they learned during their training at the HTC in outcome 1.1 and outcome 1.2 at home and transmit images to the HTC on post-training test.
Outcome 2.1: Subjects will be able to attain and transmit images of their joint spaces to the HTC via telemedicine utilizing the HHUS technology they learned in phase 1 and React App.6 monthsNumber of subjects who will be able to attain and transmit images of their joint spaces to the HTC via telemedicine utilizing the HHUS technology they learned in phase 1 and React App.
Outcome 2.2: Accuracy of the assignment of bleed vs. non-bleed will be determined on the stationary GE LS8 Logiq Pro in the HTC.6 monthsPercentage accuracy of the assignment of bleed vs. non-bleed will be determined on the stationary GE LS8 Logiq Pro in the HTC.
Outcome 3.1: To establish how accurate patient reported bleeding is compared to HHUS utilizing tele-ultrasound.3 yearsPercentage accuracy of patient reported bleeding is compared to HHUS utilizing tele-ultrasound.
Outcome 3.2: To establish more accurate bleeding data for the EmiMSKUS study.3 yearsNumber of patients who have joint bleeding data incorporated into the EmiMSKUS study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026